
Glory Lifesciences Private Limited
About Glory Lifesciences Private Limited
Data last updated:
Glory Lifesciences Private Limited was a private limited company based in New Delhi, Delhi, India, operated as a subsidiary of Rock Land Private Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 March 2008.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2008PTC174992.
The company had an authorised share capital of ₹1.7 Cr and a paid-up capital of ₹1.67 Cr. It was led by directors Riya Srivastava and Himanshu Bhandari.
Its last annual general meeting (AGM) was held on 27 September 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office was at C – 30 Panchsheel Enclave, New Delhi, Delhi, India – 110017.
Company details
Contact details
Glory Lifesciences Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC – 30 Panchsheel Enclave, New Delhi, Delhi, India – 110017
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Glory Lifesciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Glory Lifesciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of Glory Lifesciences Private Limited
FY 2021 filings availableFinancial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ||||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ||||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | ||||
| Net Profit Margin | ||||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Glory Lifesciences Private Limited, buy the company report.
Board of directors of Glory Lifesciences Private Limited
Glory Lifesciences has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Riya Srivastava | Director | 10 May 2012 | 14 Years 6 Months | As last reported |
| Himanshu Bhandari Also directs: Lipi Finstock Limited | Director | 24 Dec 2008 | 17 Years 10 Months | As last reported |
Auditor
Glory Lifesciences Private Limited is audited by A K N B M & COMPANY for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A K N B M & COMPANY | FY 2018 | 028887N |
Shareholding
The shareholding of Glory Lifesciences Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Glory Lifesciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Glory Lifesciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Glory Lifesciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Glory Lifesciences Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Glory Lifesciences Private Limited has 5 board changes on record since 2008: 2 appointments and 3 cessations. The latest: Riya Srivastava ceased to be Additional Director on 29 Sep 2012.
Frequently asked questions
Glory Lifesciences has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Glory Lifesciences was a private limited company based in New Delhi, Delhi, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 05 March 2008 and is registered under CIN U24100DL2008PTC174992. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Glory Lifesciences was incorporated on 05 March 2008. It is registered with the Registrar of Companies, Delhi.
Glory Lifesciences had 2 directors:
- Riya Srivastava - Director
- Himanshu Bhandari - Director
The CIN (Corporate Identification Number) of Glory Lifesciences is U24100DL2008PTC174992. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Glory Lifesciences is at C – 30 Panchsheel Enclave, New Delhi, Delhi, India – 110017.
The latest financial statements of Glory Lifesciences on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 27 September 2021. Year-wise statements from 2015 are in the company report.
Glory Lifesciences operated in the pharma industry, in the drug formulation and development segment.
Riya Srivastava ceased to be Additional Director on 29 Sep 2012. Yogesh Verma ceased to be Director on 11 May 2012. Riya Srivastava was appointed as Director on 10 May 2012. Glory Lifesciences has 5 board changes on record in total.
The compliance status of Glory Lifesciences is compliant as of 26 August 2026.

